Lensar, Inc. (LNSR) — SEC Filings
Lensar, Inc. (LNSR) — 27 SEC filings. Latest: 8-K (Mar 31, 2026). Includes 12 8-K, 5 10-Q, 4 SC 13G/A.
View Lensar, Inc. on SEC EDGAR
Overview
Lensar, Inc. (LNSR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 31, 2026: LENSAR, Inc. filed an 8-K on March 31, 2026, reporting its financial results and condition for the period ending March 31, 2026. The filing includes financial statements and exhibits, with the primary document being the 8-K itself in iXBRL format.
Sentiment Summary
Across 27 filings, the sentiment breakdown is: 1 bearish, 25 neutral, 1 mixed. The dominant filing sentiment for Lensar, Inc. is neutral.
Filing Type Overview
Lensar, Inc. (LNSR) has filed 12 8-K, 5 10-Q, 2 DEF 14A, 1 DEFA14A, 1 10-K/A, 2 10-K, 4 SC 13G/A with the SEC between Feb 2024 to Mar 2026.
Filings by Year
Recent SEC Filings (27)
Risk Profile
Risk Assessment: Of LNSR's 22 recent filings, 1 were flagged as high-risk, 8 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $42.410M |
| Net Income | -$32.822M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $7.637M |
| Operating Margin | N/A |
| Total Assets | N/A |
| Total Debt | N/A |
Key Executives
- William J. Link, PhD
- Nicholas T. Curtis
- Todd B. Hammer
- Aimee S. Weisner
- Alan B. Connaughton
- Thomas R. Staab, II
- Dr. Jeffrey Spragens
- Ms. Laura L. E. Smith
Industry Context
The ophthalmic surgical device market, particularly for cataract surgery, is competitive and driven by technological innovation. Companies like LENSAR focus on robotic and laser-based systems to improve surgical precision and patient outcomes. The industry is characterized by significant R&D investment and regulatory oversight.
Top Tags
corporate-governance (4) · financials (4) · medical-devices (4) · results-of-operations (3) · 10-Q (3) · Medical Devices (2) · Cataract Surgery (2) · Cash Burn (2) · Proxy Statement (2) · Virtual Meeting (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $32.822M | Increased 158% for nine months ended Sept 30, 2025, from $12.702M in 2024 |
| Net Cash Used in Operating Activities | $15.449M | For nine months ended Sept 30, 2025, compared to $5.932M in 2024 |
| Cash and Cash Equivalents | $7.637M | As of Sept 30, 2025, down from $16.263M at Dec 31, 2024 |
| Total Revenue | $42.410M | Increased 15.3% for nine months ended Sept 30, 2025, from $36.763M in 2024 |
| Selling, General and Administrative Expenses | $34.827M | Increased from $19.657M for nine months ended Sept 30, 2024 |
| Change in Fair Value of Warrant Liabilities | $13.648M | Expense for nine months ended Sept 30, 2025, compared to $3.838M expense in 2024 |
| Common Stock Outstanding | 11,944,546 | As of October 24, 2025 |
| Shares of common stock outstanding | 11,944,546 | Entitled to vote as of October 24, 2025 |
| Shares of Series A Convertible Preferred Stock outstanding | 20,000 | Entitled to vote as of October 24, 2025 |
| Filing Date | 2025-11-05 | Date DEF 14A was filed |
| Annual Meeting Date | 2025-12-18 | Date of the virtual annual meeting |
| Annual Meeting Time | 11:00 a.m. | Eastern Time for the virtual annual meeting |
| Record Date | 2025-10-24 | Stockholders of record entitled to vote |
| Director Term Expiration | 2028 | Year Class II directors' terms expire |
| SEC File Number | 001-39473 | Identifies the company's filing with the SEC. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Lensar, Inc. (LNSR)?
Lensar, Inc. has 27 recent SEC filings from Feb 2024 to Mar 2026, including 12 8-K, 5 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LNSR filings?
Across 27 filings, the sentiment breakdown is: 1 bearish, 25 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Lensar, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Lensar, Inc. (LNSR) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Lensar, Inc.?
Key financial highlights from Lensar, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for LNSR?
The investment thesis for LNSR includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Lensar, Inc.?
Key executives identified across Lensar, Inc.'s filings include William J. Link, PhD, Nicholas T. Curtis, Todd B. Hammer, Aimee S. Weisner, Alan B. Connaughton and 3 others.
What are the main risk factors for Lensar, Inc. stock?
Of LNSR's 22 assessed filings, 1 were flagged high-risk, 8 medium-risk, and 13 low-risk.
What are recent predictions and forward guidance from Lensar, Inc.?
Forward guidance and predictions for Lensar, Inc. are extracted from SEC filings as they are enriched.